The Faculty
PharmaDeals Academy consists of a group of highly experienced individuals including:
Fintan Walton PhD (CEO of PharmaVentures)
As well as leading the workshops for over 8 years, Dr Walton has spoken at many leading industry events detailing how organisations can drive greater value from their deals, these include; Drug Delivery Partnerships, Strategic Alliances, Business Development and Outsourcing.
Scott Gorman, PhD MBA (VP Business Development)
Scott has worked internationally with scores of established and emerging pharmaceutical companies in all therapeutic areas providing bespoke advice on strategy, planning, business and market evaluations, product and technology valuations, due diligence including Expert’s Reports for IPOs, partnering/negotiation and litigation support. Scott is also a director of PharmaVentures’ Negotiating Workshops, lecturing at and leading workshop discussions. Formerly, Scott was with Cobra Therapeutics and Wellcome (now GlaxoSmithKline). Scott earned his BS (hons) from the University of Kentucky, his PhD from the University of Pennsylvania and his MBA from Warwick University.
Tibor Papp MD PhD MBA (Head of Consulting)
Tibor has been involved in some of the most critical issues of the industry including decline of pipeline productivity, managing the mature product portfolio, funding of early stage R&D compounds, responding to new regulatory challenges, globalisation and maximising the value of alliances.
John Janes BSc(Hons) MA (Managing Consultant)
John has over 25 years experience in the healthcare sector, and has worked for the NHS, and for diagnostics, pharmaceutical and pharma service companies.